Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 420

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 420
---
9, not including potential patent term adjustments or patent term extensions. 263

Designer ligands of TGF-ß superfamily (Licensed Patent Rights) (0)
WO 2010 / 099219, Exclusive License Agreement between Joint Center for Biosciences and Darnatein

| Country 
 Code    |     | Type |     | Filing date |     |        Filing no. |     | Grant Date |     |     Grant no. |     |     Publ. No. |     | Expiry     |     | Status            |
| WO      |     | PCT  |     | 24/02/2010  |     | PCT/US2010/025260 |     |            |     |               |     |   2010/099219 |     |            |     |                   |
| EP      |     | PCT  |     | 24/02/2010  |     |          10746779 |     | 10/02/2016 |     |     2401293B1 |     |       2401293 |     | 24/02/2030 |     | granted           |
| KR      |     | PCT  |     | 24/02/2010  |     |     1020117021911 |     | 12/10/2015 |     | 1015586420000 |     | 1020110121642 |     | 24/02/2030 |     | granted           |
| CA      |     | PCT  |     | 24/02/2010  |     |         2752647A1 |     |            |     |               |     |       2752647 |     | 24/02/2030 |     | Under Examination |
| JP      |     | PCT  |     | 24/02/2010  |     |        2011551315 |     | 20/11/2015 |     |       5841845 |     |    2012518420 |     | 24/02/2030 |     | granted           |

DRT-101 (SAB-704) (1) WO 2020 / 101366, Activin / bmp7 chimeras: super-active sab704 and sab715, and their respective noggin-sensitized variants, nab704 and nab715; and